Patients relying on a temporary heart pump to stay alive face a direct threat: the FDA classified a recall of Abiomed’s Impella CP Sets with SmartAssist as Class I, its most serious category, warning ...

There are new and revised warnings about the instructions for use of a certain type of heart pump that could lead to a risk of heart perforation, according to an alert issued by the pump’s ...

Add Yahoo as a preferred source to see more of our stories on Google. Johnson & Johnson's Impella CP heart pump in an illustration of the heart. Johnson & Johnson's Impella heart pump failed to lower ...

Go to source) Rather than focusing only on patients with advanced heart disease, the researchers examined individuals across a spectrum of cardiac function. Their findings strengthen the concept of ...

An international trial of the Impella heart pump in patients with ST elevation myocardial infarction (STEMI) and cardiogenic shock has been stopped by the sponsor Abiomed, Inc. The termination ...

Researchers from the Philippines, China, and Taiwan have developed an artificial intelligence (AI) model that can predict how ...

Physicians at Emory University Hospital performed the first-ever surgical implantation in the United States of a brand-new type of heart pump designed to help save patients with heart failure, using a ...

Researchers at the University Medical Center Göttingen (UMG) and the University Hospital of Schleswig-Holstein (UKSH) have made a significant breakthrough in the treatment of severe heart failure: For ...

DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD) announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump. Impella ECP is the smallest heart ...

The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary ...